1. 276 INFERIOR OUTCOME IN LOW-RISK MYELODYSPLASTIC SYNDROME PATIENTS EXHIBITING IRON OVERLOAD. Issue 1 (April 2015) Authors: Sumoza, M.; Yellapragada, S.; Roque, W.; Mims, M.; Rivero, G. Journal: Leukemia research Issue: Volume 39:Issue 1(2015:Jan.) Page Start: S138 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P1102: A PHASE 1 STUDY OF PARSACLISIB IN COMBINATION WITH RITUXIMAB, BENDAMUSTINE + RITUXIMAB, OR IBRUTINIB IN PATIENTS WITH PREVIOUSLY TREATED B-CELL LYMPHOMA (CITADEL-112): PRELIMINARY SAFETY RESULTS. (23rd June 2022) Authors: Sancho, J.-M.; Lopez-Guillermo, A.; Abrisqueta, P.; Kumar, A.; Cordoba, R.; Tani, M.; Zhao, W.; Rappold, E.; Langmuir, P.; Mims, M. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 992 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗